Large-scale DNA methylation expression analysis across 12 solid cancers reveals hypermethylation in the calcium-signaling pathway

Tumorigenesis is linked to the role of DNA methylation in gene expression regulation. Yet, cancer is a highly heterogeneous disease in which the global pattern of DNA methylation and gene expression, especially across diverse cancers, is not well understood. We investigated DNA methylation status and its association with gene expressions across 12 solid cancer types obtained from The Cancer Genome Atlas. Results showed that global hypermethylation was an important characteristic across all 12 cancer types. Moreover, there were more epigenetically silenced than epigenetically activated genes across the cancers. Further analysis identified epigenetically silenced genes shared in the calcium-signaling pathway across the different cancer types. Reversing the aberrant DNA methylation of genes involved in the calcium-signaling pathway could be an effective strategy for suppressing cancers and developing anti-cancer drugs.

[1]  S. Baylin,et al.  Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction? , 2006, Nature Reviews Cancer.

[2]  Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses. , 2015, Cell.

[3]  T. Weymouth,et al.  LRpath analysis reveals common pathways dysregulated via DNA methylation across cancer types , 2012, BMC Genomics.

[4]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[5]  D. Gold,et al.  Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation , 2008, Nature Genetics.

[6]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[7]  Chunlong Zhang,et al.  The Identification of Specific Methylation Patterns across Different Cancers , 2015, PloS one.

[8]  Hsien-Da Huang,et al.  MethHC: a database of DNA methylation and gene expression in human cancer , 2014, Nucleic Acids Res..

[9]  Tae-Wook Kang,et al.  MENT: methylation and expression database of normal and tumor tissues. , 2013, Gene.

[10]  S. O'toole,et al.  Dysregulation of Hedgehog, Wnt and Notch signalling pathways in breast cancer. , 2009, Histology and histopathology.

[11]  S. Baylin,et al.  Targeting Calcium Signaling Induces Epigenetic Reactivation of Tumor Suppressor Genes in Cancer. , 2016, Cancer Research.

[12]  Gerhard Christofori,et al.  Cell adhesion and signalling by cadherins and Ig-CAMs in cancer , 2004, Nature Reviews Cancer.

[13]  M. Ehrlich.  DNA hypomethylation in cancer cells. , 2009, Epigenomics.

[14]  Michael J. Ziller,et al.  Locally disordered methylation forms the basis of intratumor methylome variation in chronic lymphocytic leukemia. , 2014, Cancer cell.

[15]  Hua Yu,et al.  COHCAP: an integrative genomic pipeline for single-nucleotide resolution DNA methylation analysis , 2013, Nucleic acids research.

[16]  A. Ray,et al.  Balance of adiponectin and leptin modulates breast cancer cell growth , 2008, Cell Research.

[17]  Gangning Liang,et al.  DNA methylation screening identifies driver epigenetic events of cancer cell survival. , 2012, Cancer cell.

[18]  G. Calaf,et al.  Differential expression of cell adhesion molecules in an ionizing radiation-induced breast cancer model system. , 2013, Oncology reports.

[19]  Peter A. Jones,et al.  Cancer genetics and epigenetics: two sides of the same coin? , 2012, Cancer cell.

[20]  Peter A. Jones,et al.  Targeting the cancer epigenome for therapy , 2016, Nature Reviews Genetics.

[21]  Sarah J. Roberts-Thomson,et al.  Calcium and cancer: targeting Ca2+ transport , 2007, Nature Reviews Cancer.

[22]  D. Clapham,et al.  Calcium signaling , 1995, Cell.

[23]  Yi Cui,et al.  CRISPR-dCas9 mediated TET1 targeting for selective DNA demethylation at BRCA1 promoter , 2016, Oncotarget.

[24]  C. Sander,et al.  Genome-wide analysis of non-coding regulatory mutations in cancer , 2014, Nature Genetics.

[25]  Hiroyuki Ogata,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 1999, Nucleic Acids Res..

[26]  F. Slack,et al.  MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy , 2011, Nature Reviews Cancer.

[27]  M. Esteller,et al.  Epigenetic modifications and human disease , 2010, Nature Biotechnology.

[28]  M. Ehrlich,et al.  DNA methylation in cancer: too much, but also too little , 2002, Oncogene.

[29]  E. Wiechec,et al.  Cell adhesion molecules and their relation to (cancer) cell stemness. , 2014, Carcinogenesis.

[30]  Peter A. Jones,et al.  The fundamental role of epigenetic events in cancer , 2002, Nature Reviews Genetics.

[31]  S. Brady-Kalnay,et al.  Cancer cells cut homophilic cell adhesion molecules and run. , 2011, Cancer research.

[32]  H Putter,et al.  Expression of cell adhesion molecules and prognosis in breast cancer , 2013, The British journal of surgery.

[33]  F. Davis,et al.  Calcium Channels and Pumps in Cancer: Changes and Consequences* , 2012, The Journal of Biological Chemistry.

[34]  F. Slack.  MicroRNAs regulate expression of oncogenes. , 2013, Clinical chemistry.

[35]  R. Tibshirani,et al.  Pancancer analysis of DNA methylation-driven genes using MethylMix , 2015, Genome Biology.

[36]  J. Sweasy,et al.  Tipping the Balance in the Powerhouse of the Cell to “Protect” Colorectal Cancer , 2012, PLoS genetics.

[37]  Yi Zhang,et al.  Active DNA demethylation: many roads lead to Rome , 2010, Nature Reviews Molecular Cell Biology.

[38]  Julie A. Law,et al.  Establishing, maintaining and modifying DNA methylation patterns in plants and animals , 2010, Nature Reviews Genetics.

[39]  M. Beckmann,et al.  Abstract B32: Inhibiting DNA methylation causes an interferon response in cancer via dsRNA including endogenous retroviruses , 2016 .

[40]  Peter A. Jones,et al.  Epigenetics in cancer. , 2010, Carcinogenesis.

[41]  Prachi Mishra,et al.  DNA hypermethylation as a chemotherapy target. , 2011, Cellular signalling.

[42]  Wei Dong Chen,et al.  Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer , 2004, Nature Genetics.

[43]  J. Herman,et al.  Gene silencing in cancer in association with promoter hypermethylation. , 2003, The New England journal of medicine.

[44]  Peter A. Jones,et al.  The Epigenomics of Cancer , 2007, Cell.

[45]  W. Chiu,et al.  Remodeling of calcium signaling in tumor progression , 2013, Journal of Biomedical Science.

[46]  C. Plass,et al.  Pan-cancer patterns of DNA methylation , 2014, Genome Medicine.

[47]  Rafael A Irizarry,et al.  Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.